Literature DB >> 22313638

Granulocyte-colony stimulating factor promotes proliferation, migration and invasion in glioma cells.

Juntao Wang1, Linli Yao, Shidou Zhao, Xiaodan Zhang, Junyi Yin, Yanmin Zhang, Xueran Chen, Ming Gao, Eng-Ang Ling, Aijun Hao, Gang Li.   

Abstract

Sustaining proliferative signaling is one of the hallmarks of cancer. Granulocyte-colony stimulating factor (G-CSF), a hematopoietic growth factor that controls proliferation and differentiation of neural stem cells, may contribute to the development of glioma. In the present study, we evaluated the expression of G-CSF and its receptor (G-CSFR) in various grades of glioma samples and primary cell culture derived from a glioblastoma patient as well as different human glioma cell lines. We showed that G-CSF and G-CSFR were widely expressed by glioma samples, primary glioma cell culture and glioma cell lines. The expression levels of G-CSF and G-CSFR were not significantly different between different grades of glioma. G-CSF promoted proliferation, migration and invasion of glioma cells. Neutralization of G-CSFR with its antibody inhibited growth and metastasis of glioma cells in vitro. We also showed that activation of signal transducer and activator transcription 3 (STAT 3) as well as expression of several of its downstream effectors was regulated by G-CSF. Taken together, the present results suggest that G-CSF contributes to glioma progression that may be linked to glioma genesis and recurrence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22313638     DOI: 10.4161/cbt.19237

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  23 in total

1.  A Novel Endogenous Damage Signal, CSF-2, Activates Multiple Beneficial Functions of Adipose Tissue-Derived Mesenchymal Stem Cells.

Authors:  Se-Ra Park; Ara Cho; Jae-Wan Kim; Hwa-Yong Lee; In-Sun Hong
Journal:  Mol Ther       Date:  2019-03-19       Impact factor: 11.454

2.  Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma.

Authors:  Hiromi Kanno; Hiroshi Nishihara; Lei Wang; Sayaka Yuzawa; Hiroyuki Kobayashi; Masumi Tsuda; Taichi Kimura; Mishie Tanino; Shunsuke Terasaka; Shinya Tanaka
Journal:  Neuro Oncol       Date:  2013-03-28       Impact factor: 12.300

3.  Synergistic inhibition of angiogenesis and glioma cell-induced angiogenesis by the combination of temozolomide and enediyne antibiotic lidamycin.

Authors:  Xing-Qi Li; Zhi-Gang Ouyang; Sheng-Hua Zhang; Hong Liu; Yue Shang; Yi Li; Yong-Su Zhen
Journal:  Cancer Biol Ther       Date:  2014-01-14       Impact factor: 4.742

4.  Granulocyte colony-stimulating factor (G-CSF) upregulates β1 integrin and increases migration of human trophoblast Swan 71 cells via PI3K and MAPK activation.

Authors:  Verónica A Furmento; Julieta Marino; Viviana C Blank; María Florencia Cayrol; Graciela A Cremaschi; Rubén C Aguilar; Leonor P Roguin
Journal:  Exp Cell Res       Date:  2016-03-15       Impact factor: 3.905

Review 5.  The dark side of granulocyte-colony stimulating factor: a supportive therapy with potential to promote tumour progression.

Authors:  Belinda Yeo; Andrew D Redfern; Kellie A Mouchemore; John A Hamilton; Robin L Anderson
Journal:  Clin Exp Metastasis       Date:  2018-07-02       Impact factor: 5.150

6.  Circulating galectins -2, -4 and -8 in cancer patients make important contributions to the increased circulation of several cytokines and chemokines that promote angiogenesis and metastasis.

Authors:  C Chen; C A Duckworth; B Fu; D M Pritchard; J M Rhodes; L-G Yu
Journal:  Br J Cancer       Date:  2014-01-02       Impact factor: 7.640

Review 7.  Glioblastoma multiforme - an overview.

Authors:  Kaja Urbańska; Justyna Sokołowska; Maciej Szmidt; Paweł Sysa
Journal:  Contemp Oncol (Pozn)       Date:  2014-08-04

Review 8.  A role for G-CSF and GM-CSF in nonmyeloid cancers.

Authors:  Alexander M Aliper; Victoria P Frieden-Korovkina; Anton Buzdin; Sergey A Roumiantsev; Alex Zhavoronkov
Journal:  Cancer Med       Date:  2014-04-02       Impact factor: 4.452

9.  HDACIs and the inhibition of invasive potential.

Authors:  Paul Dent
Journal:  Cancer Biol Ther       Date:  2013-08-15       Impact factor: 4.742

Review 10.  Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types.

Authors:  In-Sun Hong
Journal:  Exp Mol Med       Date:  2016-07-01       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.